Omar Habeeb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omar Habeeb has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Steven D. Billings
Department of Pathology and Laboratory Medicine Cleveland Clinic Cleveland Ohio USA
4 shared publications Caroline Astbury
Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA
2 shared publications- Charlotte R. Foster
Histopathology Department, LabPlus, Auckland City Hospital, Auckland, New Zealand
2 shared publications - Jennifer Susan Ko
Department of Pathology Cleveland Clinic Cleveland Ohio USA
2 shared publications - Alastair Droop
Biosciences Technology Facility, Department of Biology, University of York, York, UK
1 shared publication - Amy S. Joehlin-Price
Department of Pathology, Cleveland Clinic (K.S.D., E.A., C.L., K.B., J.K.M.K., A.S.J.P.)
1 shared publication
Latest Publications
- 29 June 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1)
Pitfalls in Bone and Soft Tissue Pathology of the Head and Neck: Primary Intraosseous Rhabdomyosarcoma/FUS::TFCP2-Rearranged Spindle Cell Rhabdomyosarcoma and Transdifferentiated/Dedifferentiated/Undifferentiated Melanoma
Because of their relative rarity, bone and soft tissue lesions of the head and neck region can present a diagnostic challenge to anatomic pathologists who practice in a general surgical pathology model-while novel lesions may be unfamiliar to subspecialty head and neck pathologists. This review focuses on a diagnostically confounding neoplasm that arises in the bone (primary intraosseous rhabdomyosarcoma / FUS::TFCP2-rearranged spindle cell rhabdomyosarcoma) and soft tissue (trans-/de-/undifferentiated melanoma) of the head and neck region-each of which can easily be mistaken for more common entities. The clinical, radiological, and histopathologic findings (including the molecular pathogenesis) of each neoplasm is discussed-along with selected differential diagnoses. The accurate recognition of these neoplasms ensures that patients are reviewed, treated, and followed at the appropriate multidisciplinary meeting.
- 29 June 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1)
Pitfalls in Bone and Soft Tissue Pathology of the Head and Neck: Primary Intraosseous Rhabdomyosarcoma/FUS::TFCP2-Rearranged Spindle Cell Rhabdomyosarcoma and Transdifferentiated/Dedifferentiated/Undifferentiated Melanoma
Because of their relative rarity, bone and soft tissue lesions of the head and neck region can present a diagnostic challenge to anatomic pathologists who practice in a general surgical pathology model-while novel lesions may be unfamiliar to subspecialty head and neck pathologists. This review focuses on a diagnostically confounding neoplasm that arises in the bone (primary intraosseous rhabdomyosarcoma / FUS::TFCP2-rearranged spindle cell rhabdomyosarcoma) and soft tissue (trans-/de-/undifferentiated melanoma) of the head and neck region-each of which can easily be mistaken for more common entities. The clinical, radiological, and histopathologic findings (including the molecular pathogenesis) of each neoplasm is discussed-along with selected differential diagnoses. The accurate recognition of these neoplasms ensures that patients are reviewed, treated, and followed at the appropriate multidisciplinary meeting.
- 13 March 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (8) , 1565-1571
Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism
Desmoid fibromatosis is a myofibroblastic neoplasm of intermediate biologic potential, which has a strong predilection for local recurrence but does not metastasize. Arranged in long, sweeping fascicles with infiltrative borders, desmoid fibromatosis typically consists of uniform, bland myofibroblastic spindle cells that harbor mutation of CTNNB1 (or less often APC) . In this report, we present a remarkable case of desmoid fibromatosis associated with striking nuclear pleomorphism. We hypothesize that this striking pleomorphism is due to a germline TP53 mutation, a finding first suspected due to strong and diffuse p53 staining by immunohistochemistry and subsequently confirmed by molecular testing. The combination of the pleomorphism and TP53 mutation in desmoid fibromatosis represents a novel finding unreported in the literature.
- 13 March 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (8) , 1565-1571
Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism
Desmoid fibromatosis is a myofibroblastic neoplasm of intermediate biologic potential, which has a strong predilection for local recurrence but does not metastasize. Arranged in long, sweeping fascicles with infiltrative borders, desmoid fibromatosis typically consists of uniform, bland myofibroblastic spindle cells that harbor mutation of CTNNB1 (or less often APC) . In this report, we present a remarkable case of desmoid fibromatosis associated with striking nuclear pleomorphism. We hypothesize that this striking pleomorphism is due to a germline TP53 mutation, a finding first suspected due to strong and diffuse p53 staining by immunohistochemistry and subsequently confirmed by molecular testing. The combination of the pleomorphism and TP53 mutation in desmoid fibromatosis represents a novel finding unreported in the literature.
- 6 December 2022
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (7) , 1347-1351
Primary Bilateral Intraosseous Rosai-Dorfman Disease
Rosai-Dorfman disease (RDD) is a rare histiocytic proliferative disease of unknown etiology. Typically presenting with cervical adenopathy and constitutional symptoms, RDD involves bone in less than 10% of cases—and rarely presents as a primary intraosseous lesion. In this report, we describe the presentation of primary, bilateral intraosseous RDD, the first known case in the literature. Asymmetrically involving the lateral femoral condyles of a 59-year-old male, the lesion was discovered incidentally during evaluation and workup for giant cell tumor of bone involving the left tibia. Confirmation of the diagnosis required multiple biopsies and extensive evaluation—reflecting the diagnostic challenge associated with this case. We discuss the clinical, radiological, and pathological findings that allowed us to establish the diagnosis—as well as key differential diagnostic considerations and clinical outcome to date.
- 6 December 2022
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (7) , 1347-1351
Primary Bilateral Intraosseous Rosai-Dorfman Disease
Rosai-Dorfman disease (RDD) is a rare histiocytic proliferative disease of unknown etiology. Typically presenting with cervical adenopathy and constitutional symptoms, RDD involves bone in less than 10% of cases—and rarely presents as a primary intraosseous lesion. In this report, we describe the presentation of primary, bilateral intraosseous RDD, the first known case in the literature. Asymmetrically involving the lateral femoral condyles of a 59-year-old male, the lesion was discovered incidentally during evaluation and workup for giant cell tumor of bone involving the left tibia. Confirmation of the diagnosis required multiple biopsies and extensive evaluation—reflecting the diagnostic challenge associated with this case. We discuss the clinical, radiological, and pathological findings that allowed us to establish the diagnosis—as well as key differential diagnostic considerations and clinical outcome to date.
- 1 November 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 42-50
MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas
- 1 November 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 42-50
MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas
- 1 November 2021
- Published by Elsevier in Laboratory Investigation
- Vol. 34 (11) , 2009-2019
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma
- 1 November 2021
- Published by Elsevier in Laboratory Investigation
- Vol. 34 (11) , 2009-2019
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma
- 9 September 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 48 (2) , 255-262
EWSR1‐SMAD3 rearranged fibroblastic tumor: Case series and review
We report the largest series to date (N = 6) of EWSR1‐SMAD3 rearranged fibroblastic tumor. Initially described in 2018, the tumor features a marked female predominance (F:M, 5:1, mean age 44‐years, median age 45.5 years; range 27‐57), with most cases (5/6, 83%) arising in acral locations (4 on foot/toe, 1 on hand). One case presented on the lower extremity. The lesions presented as nodules and were composed of short, variably cellular, intersecting fascicles of uniform spindled cells in a collagenous to myxoid stroma. In four cases, the tumor abutted the epidermis without a grenz zone. In one case, there was an abrupt transition to a central, acellular hyalinized area. Two other cases had admixed smaller collagenous areas, reminiscent of collagen rosettes. One had a concentric arrangement of tumor cells around blood vessels. Mitotic activity was low (EWSR1‐SMAD3 fusion was identified in three cases tested by next‐generation sequencing (3/3). Rearrangement of EWSR1 by fluorescence in situ hybridization was showed in 1/1 case. Our series reaffirms prior findings and expands the known histopathologic spectrum of this emerging entity.
- 9 September 2020
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 48 (2) , 255-262
EWSR1‐SMAD3 rearranged fibroblastic tumor: Case series and review
We report the largest series to date (N = 6) of EWSR1‐SMAD3 rearranged fibroblastic tumor. Initially described in 2018, the tumor features a marked female predominance (F:M, 5:1, mean age 44‐years, median age 45.5 years; range 27‐57), with most cases (5/6, 83%) arising in acral locations (4 on foot/toe, 1 on hand). One case presented on the lower extremity. The lesions presented as nodules and were composed of short, variably cellular, intersecting fascicles of uniform spindled cells in a collagenous to myxoid stroma. In four cases, the tumor abutted the epidermis without a grenz zone. In one case, there was an abrupt transition to a central, acellular hyalinized area. Two other cases had admixed smaller collagenous areas, reminiscent of collagen rosettes. One had a concentric arrangement of tumor cells around blood vessels. Mitotic activity was low (EWSR1‐SMAD3 fusion was identified in three cases tested by next‐generation sequencing (3/3). Rearrangement of EWSR1 by fluorescence in situ hybridization was showed in 1/1 case. Our series reaffirms prior findings and expands the known histopathologic spectrum of this emerging entity.